These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35358712)
21. Diagnosis and Medical Management of Ocular Surface Squamous Neoplasia. Sayed-Ahmed IO; Palioura S; Galor A; Karp CL Expert Rev Ophthalmol; 2017; 12(1):11-19. PubMed ID: 28184236 [TBL] [Abstract][Full Text] [Related]
22. Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings. Singh M; Gautam N; Kaur M Int Ophthalmol; 2019 Feb; 39(2):295-301. PubMed ID: 29362973 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes. Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750 [TBL] [Abstract][Full Text] [Related]
24. Corneal squamous neoplasia: masquerades and management outcomes at a rural eyecare centre. Agarwal A; Kaliki S; Murthy SI BMJ Case Rep; 2023 May; 16(5):. PubMed ID: 37130635 [TBL] [Abstract][Full Text] [Related]
25. Interferon Alfa-2b for Pigmented Ocular Surface Squamous Neoplasia: A Report of 8 Lesions. Kaliki S; Sharma A; Vempuluru VS Cornea; 2021 Feb; 40(2):142-146. PubMed ID: 32355112 [TBL] [Abstract][Full Text] [Related]
26. Changes in in vivo confocal microscopic findings of ocular surface squamous neoplasia during treatment with topical interferon alfa-2b. Zarei-Ghanavati M; Mousavi E; Nabavi A; Latifi G; Mehrjardi HZ; Mohebbi M; Ghassemi H; Mirzaie F; Zare MA Ocul Surf; 2018 Apr; 16(2):235-241. PubMed ID: 29306088 [TBL] [Abstract][Full Text] [Related]
27. Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease. Zhang L; Mercado C; Galor A; Holland EJ; Wang G; Karp CL Ocul Immunol Inflamm; 2019; 27(2):288-293. PubMed ID: 29190165 [TBL] [Abstract][Full Text] [Related]
28. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification. Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208 [TBL] [Abstract][Full Text] [Related]
29. Use of High-Resolution Optical Coherence Tomography in the Surgical Management of Ocular Surface Squamous Neoplasia: A Pilot Study. Karp CL; Mercado C; Venkateswaran N; Ruggeri M; Galor A; Garcia A; Sivaraman KR; Fernandez MP; Bermudez A; Dubovy SR Am J Ophthalmol; 2019 Oct; 206():17-31. PubMed ID: 31163136 [TBL] [Abstract][Full Text] [Related]
30. Anterior segment optical coherence tomography characteristics of conjunctival papilloma as compared to papilliform ocular surface squamous neoplasia. Sripawadkul W; Khzam RA; Tang V; Zein M; Dubovy SR; Galor A; Karp CL Eye (Lond); 2023 Apr; 37(5):995-1001. PubMed ID: 36402855 [TBL] [Abstract][Full Text] [Related]
31. Observational study of ocular surface squamous neoplasia: Risk factors, diagnosis, management and outcomes at a tertiary eye hospital in South Africa. Hӧllhumer R; Williams S; Michelow P PLoS One; 2020; 15(8):e0237453. PubMed ID: 32780766 [TBL] [Abstract][Full Text] [Related]
33. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary? Chaugule SS; Park J; Finger PT Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124 [TBL] [Abstract][Full Text] [Related]
34. Long-Term Efficacy and Safety of Subconjunctival/Perilesional 5-Fluorouracil Injections for Ocular Surface Squamous Neoplasia. Sun Y; Hua R Drug Des Devel Ther; 2020; 14():5659-5665. PubMed ID: 33376309 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis and management of conjunctival and corneal intraepithelial neoplasia using ultra high-resolution optical coherence tomography. Shousha MA; Karp CL; Perez VL; Hoffmann R; Ventura R; Chang V; Dubovy SR; Wang J Ophthalmology; 2011 Aug; 118(8):1531-7. PubMed ID: 21507486 [TBL] [Abstract][Full Text] [Related]
36. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578 [TBL] [Abstract][Full Text] [Related]
37. Comparison of ocular surface squamous neoplasia and pterygium using anterior segment optical coherence tomography angiography. Nampei K; Oie Y; Kiritoshi S; Morota M; Satoh S; Kawasaki S; Nishida K Am J Ophthalmol Case Rep; 2020 Dec; 20():100902. PubMed ID: 32995664 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of topical 0.5% 5-Fluorouracil as primary treatment of ocular surface squamous neoplasia. Kato JM; Ballalai PL; de Lima PP; Santo RM Can J Ophthalmol; 2024 Oct; 59(5):e510-e514. PubMed ID: 38631493 [TBL] [Abstract][Full Text] [Related]
39. Topical interferon or surgical excision for the management of primary ocular surface squamous neoplasia. Sturges A; Butt AL; Lai JE; Chodosh J Ophthalmology; 2008 Aug; 115(8):1297-302, 1302.e1. PubMed ID: 18294690 [TBL] [Abstract][Full Text] [Related]
40. Ocular surface squamous neoplasia: management and outcomes. Hӧllhumer R; Williams S; Michelow P Eye (Lond); 2021 Jun; 35(6):1562-1573. PubMed ID: 33564137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]